Pharmacodynamic evaluation of YKP3089 in epilepsy patients with a photo-induced paroxysmal EEG [electroencephalography]-response: proof of principle.
Phase of Trial: Phase II
Latest Information Update: 26 Dec 2013
At a glance
- Drugs Cenobamate (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors SK Life Science
- 12 Jun 2012 Actual patient number is 11 as reported by ClincialTrials.gov.
- 13 Jul 2011 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 13 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.